6th Annual NHLBI Progenitor Cell Translational Consortium (PCTC) 2023

The 6th Annual NHLBI Progenitor Cell Translational Consortium (PCTC) 2023 is dedicated to developments in the study of progenitor cells biology towards application to lung, heart and blood diseases with a focus on the use of progenitor cell-based disease models to understand disease mechanisms and to develop therapies.

Key Topics

• The use of progenitor cells (including gene modified progenitors) and their differentiated progeny for cell therapy and tissue engineering
• Continued development of patient-specific disease models using progenitor cells and genome editing
• Expansion of efforts to employ direct reprogramming of cells in vivo to treat disease
• The development of strategies to promote the reparative potentials of endogenous progenitor cells

Who should Attend

Researchers, practitioners and physicians.